Does POMALIDOMIDE Cause Hyperkeratosis? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hyperkeratosis have been filed in association with POMALIDOMIDE (Pomalyst). This represents 0.0% of all adverse event reports for POMALIDOMIDE.
6
Reports of Hyperkeratosis with POMALIDOMIDE
0.0%
of all POMALIDOMIDE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Hyperkeratosis From POMALIDOMIDE?
Of the 6 reports.
Is Hyperkeratosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POMALIDOMIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does POMALIDOMIDE Cause?
Plasma cell myeloma (7,023)
Death (6,795)
Fatigue (6,530)
Pneumonia (5,792)
Off label use (3,845)
Diarrhoea (3,351)
White blood cell count decreased (3,328)
Neutropenia (3,029)
Rash (2,715)
Dyspnoea (2,543)
What Other Drugs Cause Hyperkeratosis?
CABOZANTINIB S-MALATE (411)
ADALIMUMAB (332)
SUNITINIB MALATE (170)
ETANERCEPT (168)
SORAFENIB (150)
METHOTREXATE (149)
VEMURAFENIB (145)
REGORAFENIB (136)
RIPRETINIB (124)
RITUXIMAB (121)
Which POMALIDOMIDE Alternatives Have Lower Hyperkeratosis Risk?
POMALIDOMIDE vs POMALYST
POMALIDOMIDE vs PONATINIB
POMALIDOMIDE vs PONATINIB\PONATINIB
POMALIDOMIDE vs PONESIMOD
POMALIDOMIDE vs PORACTANT ALFA